News & Updates

Mental wellbeing during a pandemic

The recurrent waves of the COVID-19 pandemic are having a significant impact on healthcare workers, and Medical Protection has called for more to be done globally to ensure that medical professionals have quick access to mental wellbeing support.

Football to help end malnutrition, obesity in children

Explore the current challenges and opportunities in hypertension management in the local setting

[ Home blood pressure monitoring device ]

Progesterone-to-estradiol ratio a promising treatment target in AUD

In adults with alcohol use disorder (AUD), high progesterone-to-estradiol ratios appear protective against problematic alcohol consumption, as shown in a study. Additionally, women with AUD may derive benefits from treatments tailored to their menstrual cycle phase.

Empagliflozin near to us: Insights from its use in Asians

In this fourth issue, join us as we discover the unique biology Asians have with respect to diabetes. Take a closer look at trials evaluating whether empagliflozin’s cardiovascular and renal benefits – as analysed in Asians – are consistent with the overall trial population, and how it addresses unmet needs.

Original New Drug Application Approvals by US FDA (1-15 March 2024)

New guidelines: Paradigm shift in CV management of T2D patients

Recently published cardiovascular outcome trials (CVOTs) in patients with diabetes (DM) have led to updates in the management of cardiovascular disease (CVD) in DM patients. These updates were reflected in the 2019 ESC guidelines on diabetes, prediabetes, and CVD, a collaboration between ESC and EASD*.

Product Highlight - IVCORT

Hydrocortisone Na succinate 100 mg powd for inj

Treating type 2 diabetes mellitus with G.R.A.C.E.

A challenging aspect of glycaemic control presents in patients diagnosed with early-onset type 2 diabetes mellitus (T2DM). Considering this challenge, how can effective management of glycaemic control be achieved in patients with uncontrolled T2DM who are hesitant to incorporate multiple oral antidiabetic drugs into their current regimen? In this case study, Dr Matthew Tan shared his clinical experience in managing a young adult patient with T2DM using GLYXAMBI^®, a fixed-dose combination of empagliflozin and linagliptin taken once daily. He demonstrated how applying the G.R.A.C.E. concept to the treatment improved the patient’s clinical outcome.

This advertorial is sponsored as an educational programme by Boehringer Ingelheim Singapore Pte. Ltd.

[PD TEST]Sequential therapy beefs up bone density in women with anorexia

Administering recombinant human insulin-like growth hormone-1 (rhIGF-1) for 6 months followed by risedronate for another 6 months helps improve bone mineral density (BMD) at the spine in women with anorexia nervosa, according to a study.